Keshav Raj Paudel

About

I am a mid-career researcher (Level B) at NICM Health Research Institute, Western Sydney University, Australia, working in the field of herbal medicine and inflammatory disease, exploring disease progression and the pharmacological activity of drug candidates on various inflammatory disease models (both in vivo and in vitro), using molecular, immunological, and biochemical assays. I am interested in exploring the cell signaling pathways of various inflammation-related disorders.

Employment

• Western Sydney University Senior Researcher
  2025 - Present
• University of Technology Sydney Faculty of Health Lecturer
  2019 - 2025
• University of Texas Health Science Center at Houston Post-Doctoral Research Fellow
  2018 - 2019
• Lumbini Institute of Health Science Tutor
  2011 - 2012

Education

• Mokpo National University PhD (Pharmacology)
  2014 - Present
• Mokpo National University M.Sc. (Pharmacology)
  2012 - 2014
• Pokhara University Bachelor of Pharmacy (B.Pharm)
  2007 - 2011
• Farwest School of Medicine Diploma in Pharmacy (D.Pharm)
  2004 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (316)

• Two decades and beyond: What we know and still need to learn about the TWEAK/Fn14 pathway.
  Cellular Signalling 2026 DOI: 10.1016/j.cellsig.2026.112617
  +Save
• Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential
  Advanced Healthcare Materials 2026 DOI: 10.1002/adhm.71594
  +Save
• Proteotoxicity and tubular epithelial cell fate in acute kidney injury: Molecular insights and treatment strategies.
  Life Sciences 2026 DOI: 10.1016/j.lfs.2026.124451
  +Save
• 18-β-Glycyrrhetinic-loaded poly(lactic-co-glycolic) (PLGA) nanoparticles downregulate the expression LPS-induced proteins mediating tissue remodelling in vitro.
  Toxicology in Vitro 2026 DOI: 10.1016/j.tiv.2026.106247
  +Save
• Plant-derived essential oils in lung cancer: Anticancer mechanisms, experimental progress, and future perspectives
  Food Bioscience 2026 DOI: 10.1016/j.fbio.2026.109367
  +Save
• QbD-designed development and evaluation of bexarotene-loaded Cubosome gel for enhanced skin permeation in psoriasis treatment
  Journal of Drug Delivery Science and Technology 2026 DOI: 10.1016/j.jddst.2026.108333
  +Save
• Targeting BMP2 signaling pathway in osteogenesis and osteoarthritis: A path toward safer regenerative therapies.
  Cellular Signalling 2026 DOI: 10.1016/j.cellsig.2026.112482
  +Save
• Fisetin-loaded Nanoemulsion and Fecal Microbiome Extract Enhance In Vitro Inhibition of Non-Small Cell Lung Cancer Progression.
  Cell Biochemistry and Biophysics 2026 DOI: 10.1007/s12013-025-01981-2
  +Save
• Medicinal Insights Into FLT3 Inhibitors as Anticancer Agents: Current Status and Future Direction
  Archiv der Pharmazie 2026 DOI: 10.1002/ardp.70302
  +Save
• ROS-responsive drug delivery systems: Harnessing redox biology for targeted therapies.
  Colloids and Surfaces B: Biointerfaces 2026 DOI: 10.1016/j.colsurfb.2026.115559
  +Save